A longitudinal study investigating assessing the prediction of response to Ustekinumab based on the DNA methylome of peripheral blood (PB) obtained from refractory Crohn's-disease patients
Latest Information Update: 09 Dec 2021
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Therapeutic Use
- 09 Dec 2021 New trial record